Suppr超能文献

肿瘤坏死因子相关凋亡诱导配体(TRAIL)与死亡受体5(DR5)复合物的结构揭示了凋亡起始阶段特异性的作用机制。

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

作者信息

Mongkolsapaya J, Grimes J M, Chen N, Xu X N, Stuart D I, Jones E Y, Screaton G R

机构信息

MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK.

出版信息

Nat Struct Biol. 1999 Nov;6(11):1048-53. doi: 10.1038/14935.

Abstract

TRAIL, an apoptosis inducing ligand, has at least four cell surface receptors including the death receptor DR5. Here we report the crystal structure at 2.2 A resolution of a complex between TRAIL and the extracellular region of DR5. TRAIL forms a central homotrimer around which three DR5 molecules bind. Radical differences in the surface charge of the ligand, together with variation in the alignment of the two receptor domains confer specificity between members of these ligand and receptor families. The existence of a switch mechanism allowing variation in receptor domain alignment may mean that it is possible to engineer receptors with multiple specificities by exploiting contact positions unique to individual receptor-ligand pairs.

摘要

肿瘤坏死因子相关凋亡诱导配体(TRAIL)是一种凋亡诱导配体,它至少有四种细胞表面受体,包括死亡受体DR5。在此,我们报道了TRAIL与DR5细胞外区域复合物的晶体结构,分辨率为2.2埃。TRAIL形成一个中心同源三聚体,三个DR5分子围绕该三聚体结合。配体表面电荷的显著差异,以及两个受体结构域排列的变化,赋予了这些配体和受体家族成员之间的特异性。存在一种允许受体结构域排列变化的转换机制,这可能意味着通过利用单个受体-配体对特有的接触位置来设计具有多种特异性的受体是可行的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验